INTRALIPID 20% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Intralipid 20%, and when can generic versions of Intralipid 20% launch?
Intralipid 20% is a drug marketed by Fresenius and is included in two NDAs.
The generic ingredient in INTRALIPID 20% is soybean oil. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INTRALIPID 20%?
- What are the global sales for INTRALIPID 20%?
- What is Average Wholesale Price for INTRALIPID 20%?
Summary for INTRALIPID 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 88 |
| DailyMed Link: | INTRALIPID 20% at DailyMed |
Recent Clinical Trials for INTRALIPID 20%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Rochester | PHASE2 |
| HEPYX LIMITED | PHASE2 |
| European Association for the Study of the Liver | PHASE2 |
Pharmacology for INTRALIPID 20%
| Drug Class | Lipid Emulsion |
US Patents and Regulatory Information for INTRALIPID 20%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius | INTRALIPID 20% | soybean oil | INJECTABLE;INJECTION | 018449-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius | INTRALIPID 20% | soybean oil | INJECTABLE;INJECTION | 020248-001 | Aug 7, 1996 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
